Bolk et al., 2018 [6]
|
Sweden
|
Cohort study
|
229-preterm
344-full-term
|
6.5 years
|
Extremely preterm
|
CP, cognitive impairment, visual or hearing
impairment
|
MABC-2
|
≤5th percentile
|
85 (37.1)
|
19 (5.5)
|
Cameron et al., 2021 [33] |
Australia |
Cohort study |
48-preterm
96-full-term |
4 to 5 years |
Very preterm |
Congenital abnormalities,
IQ<70 |
L-DCDQ |
Score below 68 for females and 67 for males |
18 (38) |
29 (30) |
Caravale et al., 2019 [34] |
Italy |
Cohort study |
608-preterm
362-full-term |
9 years |
Extremely and very preterm |
CP,
malformations, vision or hearing problems, cognitive disability |
DCDQ |
<15th percentile |
185 (30.4) |
59 (16.2) |
Davis et al., 2007 [35] |
Australia |
Cohort study |
210-preterm,
202-full-term |
8 to 9 years |
Extremely preterm |
CP, IQ more than 2sds
below the mean |
MABC |
≤5th percentile |
20 (9.5) |
4
(2.0) |
de Kieviet et al., 2013 [36] |
Netherlands |
Cohort study |
58-preterm 64-full-term |
7.5 years |
Very preterm |
Serious motor,
hearing, or vision difficulties |
MABC |
<15th percentile |
27
(46) |
10 (16) |
Deshmukh, Sahu, Deshpandec, 2021 [37]
|
India
|
Cross-sectional
|
88-preterm
628-full-term
|
5 to 10 years
|
Preterm
|
CP, muscular dystrophy, mental retardation,
spinal fracture, visual, hearing and cognitive impairment
|
DCDQ 07
|
5-7years ≤46; 8-9years ≤54; 10-11years ≤56
|
26 (29.5)
|
145 (23.1)
|
Faebo Larsen et al., 2013 [38] |
Denmark |
Cohort study |
143-preterm 29044-full-term |
7 years |
Very preterm and moderate
preterm |
Unclear |
DCDC 07 |
5-7years ≤46; 8-9years ≤55; 10-11years ≤57 |
104 (7.3) |
798 (2.9) |
Foulder-Hughes, Cooke, 2003 [39] |
England |
Cohort study |
280-preterm 210-full-term |
7 to 8 years |
Very preterm |
CP |
MABC |
≤5th percentile |
86 (30.7) |
14 (6.7) |
Goyen, Lui, 2009 [40] |
Australia |
Case-control |
50-preterm;
50-full-term |
8 years |
Extremely preterm and very preterm |
Full-scale
IQ<84, neurological abnormality, visual or hearing impairment |
MABC |
<15th percentile |
21 (42) |
4 (8) |
Lingam et al., 2009 [41] |
England |
Cohort study |
367-preterm,
6614-full-term |
7.5 years |
Preterm |
Visual, developmental, or
neurologic conditions, IQ<70 |
MABC |
≤15th percentile |
27
(7.3) |
302 (4.5) |
Pierrat et al., 2021 [42] |
France |
Cohort study |
2219-preterm
592-full-term |
5.5 years |
Extremely, very and moderate preterm |
CP,
sensory disability, IQ score less than 2 SD. |
MABC - 2 |
≤5th
percentile |
194 (8.7) |
32 (5.4) |
Pritchard et al., 2014 [43] |
New Zealand |
Cohort study |
105-preterm 107-full-term |
4 years |
Very preterm |
Congenital
anomalies, fetal alcohol syndrome |
DSM-4th |
Unclear |
7 (6.6) |
2
(1.8) |
Roberts et al., 2011 [44] |
Australia |
Cohort study |
132-preterm
154-full-term |
8 years |
Extremely preterm |
CP or an intellectual
impairment. |
MABC |
≤5th percentile |
21 (16) |
8 (5) |
Spittle et al., 2021 [45]
|
Australia
|
Cohort study
|
165-preterm
65-full-term
|
5, 7 and 13 years (3 time points)
|
Very preterm
|
CP, IQ<80
|
MABC and MABC-2
|
≤16th percentile
|
79 (47.9)
|
10 (15.3)
|
Tommiska et al., 2020 [46] |
Finland |
Cohort study, |
60-preterm
30-full-term |
11 years |
Extremely preterm |
Cognitive impairment,
severe disability |
MABC |
≤5th percentile |
18 (30) |
2
(7) |
Yang et al., 2020 [47] |
China |
Case-control study |
888-preterm
7698-full-term |
3-6 years |
Preterm |
Unclear |
MABC-2 |
Score ≤71 and pediatrician to
confirm
DCD
|
78 (8.7) |
493 (6.4) |
Zhu, Olsen, Olesen, 2012 [48] |
Denmark |
Cohort study |
943-preterm
21955-full-term |
7 years |
Very and moderate preterm |
DID NOT exclude children with
diseases
like CP and mental retardation,
|
DCDQ |
Score of ≤46 |
71 (7.5) |
643
(2.9) |